Neogen Q4 revenue $236.8M down 2.1% YoY; net loss $0.02 EPS; guides FY25 rev $925-955M

NEOGEN CORP

2024-FY EPS reported -$0.04 revenue$924,222,000

Revenue $236.8M, down 2.1% YoY; core revenue grew 2.0% as FX headwind of 4.2% offset.
GAAP net loss $5.4M ($0.02 diluted); adjusted net income $22.4M ($0.10) vs $30.2M ($0.14) prior year.
Adjusted EBITDA $53.0M (22.4% margin) vs $63.1M (26.1%) prior year; gross margin fell to 47.9% from 50.9%.
Food Safety segment revenue $166.9M (-1.4% total, +4.3% core); Animal Safety $69.9M (-3.7% total, -3.3% core).
FY2025 guidance: revenue $925M-$955M (core mid-single-digit), Adj. EBITDA $215M-$235M, capex ~$85M.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.